Tango Therapeutics Inc (TNGX) earnings · rev $62.4M
These earnings events as JSON? API free 100/dayTango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
This TNGX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TNGX revenue for 2025-12-31 was $62.4M. Net income was -$101.6M. Revenue was up 48.3% from 2024-12-31 to 2025-12-31. TNGX currently screens at market cap $5.36B.
When the next TNGX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 48.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TNGX research stays on the stock page; the tape stays on the quote page.
TNGX earnings FAQ
What are TNGX's latest revenue and net income?
Latest cached Tango Therapeutics Inc (TNGX) revenue for Dec 31, 2025 was $62.4M. Net income was -$101.6M. Statements: https://lician.com/financials/tngx
What is TNGX's latest diluted EPS?
Latest cached Tango Therapeutics Inc (TNGX) diluted EPS for Dec 31, 2025 was -$0.87.
What period does the latest TNGX earnings print cover?
The latest cached Tango Therapeutics Inc (TNGX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TNGX revenue change from the prior cached period?
Cached Tango Therapeutics Inc (TNGX) revenue was up 48.3% from $42.1M (Dec 31, 2024) to $62.4M (Dec 31, 2025). Statements: https://lician.com/financials/tngx
Where are TNGX earnings listed?
Cached earnings facts for Tango Therapeutics Inc (TNGX) are listed at https://lician.com/earnings/tngx. Statements: https://lician.com/financials/tngx
Not investment advice.